TriangleFOR PATIENTS · SOURCE READING
Immunotherapy
Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Immunotherapy helps a person's immune system fight cancer. Your doctor may suggest biomarker tests to help predict your response to certain immunotherapy drugs. Learn more about Biomarker Testing for Cancer Treatment.
Source links and citations
Immunotherapy drugs used to treat non-small cell lung cancer include:
atezolizumab
Source links and citations
cemiplimab-rwlc
Source links and citations
durvalumab
Source links and citations
ipilimumab
Source links and citations
nivolumab
Source links and citations
pembrolizumab
Source links and citations
tremelimumab
Source links and citations
Learn more about Immunotherapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice